Medicine by Design
Medicine by Design, CCRM launch alliance to bolster Canada’s leading position in regenerative medicine
Medicine by Design and CCRM are launching a new strategic alliance that aims to unlock Toronto’s potential as a world-leading ecosystem for regenerative medicine.
U of T-anchored hospital network among leading life sciences research hubs, report finds
The University of Toronto and its partner hospitals are propelling the Toronto region as a leading global hub for life sciences research – but its success is at risk from underinvestment. That’s among the findings of a new report that examines the strengths and challenges within the Toronto Academic Health Science Network (TAHSN) – which comprises U of T […]
Canada’s opportunity in the future of genomics
One of U of T’s strengths lie in human genomics, which is supported by top-ranked faculty and researchers, anchored by a strong network of affiliated hospitals and medical research centers. Together, this network continues to advance frontiers of knowledge in critical areas of genomics including genetic susceptibility to disease, personalized medicine, machine learning for biomedical data, and more. Innovation hubs like the Emerging and Pandemic Infections Consortium (EPIC), Precision Medicine Initiative (PRiME), Medicine by Design, and the Structural Genomics Consortium are part of a network of high-impact interdisciplinary research centres that leverage areas of focus such as infectious disease, regenerative medicine, cell therapy, drug discovery, open science and more.
Students push the boundaries of research and innovation: Groundbreakers S2 Ep.4
In Ep. 4 of the Groundbreakers video series, host Ainka Jess goes behind the scenes with student researchers from the Robotics Institute and Medicine by Design strategic initiatives, as well as the Black Founders Network.
Some of their work is literally out of this world.
U of T partners with Moderna to advance research in RNA science and technology
U of T and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives, said U of T is excited to work alongside Moderna to protect society from current and future health threats.
Inaugural DSI Catalyst Grants support transformative data science research
The Data Sciences Institute (DSI) at the University of Toronto is funding seventeen cross-disciplinary research teams focused on using the transformative nature of data sciences to solve complex and pressing problems. “The global and research challenges we face today are increasingly complex. The DSI Catalyst Grant projects bring together collaborative research teams focused on the […]
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
By Julie Crljen|August 9th, 2021|Categories: News|Tags: cardiac, Cindi Morshead, EVLP, liver disease, lung, organ transplantation, Pivotal Experiment Fund, Shaf Keshavjee, stroke, team projects, translation The four researchers leading teams that are sharing $1 million in funding through the Pivotal Experiment Fund. Left to right: Hai-Ling Margaret Cheng, associate professor at the Institute of Biomedical Engineering, University of Toronto; Dr. Shaf Keshavjee, surgeon-in-chief at UHN’s Sprott Department of Surgery and director […]
Venture formed in the Medicine by Design community, Liberum, aims to make desktop protein manufacturing a reality
By Julie Crljen|June 29th, 2021| Members of the Liberum Team. Chris Leichthammer, lab manager (left), Aidan Tinafar, co-founder and CEO (centre) and Alex Klenov, chief technology officer (right). (Absent: Keith Pardee, co-founder and strategic advisor, and assistant professor at the Leslie Dan Faculty of Pharmacy, University of Toronto.) Proteins are the building blocks of life, and they serve numerous crucial […]
Medicine by Design-funded scientists discover a new stem cell property that could enhance life-saving blood stem cell transplants
By Paul Fraumeni|May 14th, 2021| New research from a team of University Health Network (UHN) stem cell scientists has demonstrated that blood stem cells possess a previously undescribed property that they term latency. Latency governs whether a stem cell quickly kicks into action during a transplant or whether it is delayed in getting activated. When […]
Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact
By Julie Crljen|February 9th, 2021|Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact - Medicine by Design (utoronto.ca) The gap between early-stage research funding and venture investment means some promising advances in regenerative medicine may never reach the patients who need them. Medicine by Design plans to change that with the launch of its […]
Building a Biotech Venture to help Medicine by Design trainees take first steps toward entrepreneurship
By Julie Crljen|January 15th, 2021| Building a Biotech Venture to help Medicine by Design trainees take first steps toward entrepreneurship - Medicine by Design (utoronto.ca) Trainees who are thinking about translating their regenerative medicine research or technology into a product or venture are invited to take their first steps toward entrepreneurship with Building a Biotech Venture. This […]
Medicine by Design symposium highlights importance of convergence in advancing regenerative medicine and human health
By Julie Crljen|December 16th, 2020|Categories: News (Medicine by Design symposium highlights importance of convergence in advancing regenerative medicine and human health - Medicine by Design (utoronto.ca)) Dr. Victor Dzau, President of the U.S. National Academy of Medicine (NAM), spoke about NAM’s Health Longevity Global Challenge at the Medicine by Design symposium, which was held on Dec. 7 […]